Fluids and Barriers of the CNS

Scope & Guideline

Advancing Neuroscience Through Fluid Dynamics and Barriers

Introduction

Welcome to the Fluids and Barriers of the CNS information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Fluids and Barriers of the CNS, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN2045-8118
PublisherBMC
Support Open AccessYes
CountryUnited Kingdom
TypeJournal
Convergefrom 2011 to 2024
AbbreviationFLUIDS BARRIERS CNS / Fluids Barriers CNS
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressCAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND

Aims and Scopes

The journal 'Fluids and Barriers of the CNS' primarily focuses on the study of cerebrospinal fluid (CSF) dynamics, blood-brain barrier (BBB) integrity, and their implications in central nervous system (CNS) disorders. It encompasses a multidisciplinary approach, integrating molecular biology, neuroimaging, and clinical research to advance understanding and treatment of CNS diseases.
  1. Cerebrospinal Fluid Dynamics:
    Research on the production, flow, and absorption of cerebrospinal fluid, including its role in maintaining intracranial pressure and its implications for conditions such as hydrocephalus.
  2. Blood-Brain Barrier Integrity:
    Investigating the mechanisms that regulate the permeability and function of the blood-brain barrier, particularly in the context of neurological diseases and therapeutic delivery.
  3. Neuroinflammation and Immune Response:
    Exploring the role of immune responses and neuroinflammation in CNS disorders, including the impact of various cytokines and immune cells on cerebrospinal fluid dynamics and blood-brain barrier function.
  4. Modeling and Imaging Techniques:
    Utilizing advanced imaging technologies and modeling techniques to study cerebrospinal fluid dynamics and blood-brain barrier properties, contributing to a better understanding of CNS pathophysiology.
  5. Therapeutic Approaches:
    Focusing on innovative therapeutic strategies aimed at enhancing drug delivery to the CNS, including the use of nanoparticles, ultrasound, and other methods to modulate blood-brain barrier permeability.
  6. Aging and Developmental Biology:
    Examining how aging affects cerebrospinal fluid dynamics and blood-brain barrier integrity, as well as the implications for neurodegenerative diseases.
The journal has witnessed a significant evolution in its thematic focus, with several emerging trends that reflect current scientific interests and advancements in the field. These trends highlight the integration of new technologies and methodologies to enhance understanding of CNS pathophysiology.
  1. Advanced Imaging Techniques:
    There is a growing emphasis on employing advanced imaging modalities, such as 4D flow MRI and high-resolution microimaging, to study cerebrospinal fluid dynamics and blood-brain barrier integrity in real time.
  2. In Vitro Models of the Blood-Brain Barrier:
    Research is increasingly utilizing in vitro models, including iPSC-derived and organoid systems, to better mimic the blood-brain barrier and study drug delivery mechanisms in a controlled environment.
  3. Role of the Choroid Plexus:
    Emerging studies focus on the physiological and pathological roles of the choroid plexus in cerebrospinal fluid production and its involvement in neurodegenerative diseases.
  4. Neuroinflammation and its Impact on CNS Function:
    There is a trend towards exploring the relationship between neuroinflammation, cerebrospinal fluid dynamics, and neurodegenerative disorders, emphasizing the role of cytokines and immune cells.
  5. Therapeutic Innovations for CNS Delivery:
    The journal is increasingly publishing studies on innovative therapeutic strategies, including ultrasound-mediated drug delivery and nanotechnology, aimed at enhancing therapeutic efficacy in the CNS.
  6. Aging and Neurodegeneration:
    Research on the effects of aging on cerebrospinal fluid dynamics and blood-brain barrier function is gaining traction, reflecting the increasing relevance of these factors in neurodegenerative diseases.

Declining or Waning

While 'Fluids and Barriers of the CNS' continues to expand its focus on various aspects of cerebrospinal fluid and blood-brain barrier research, some themes appear to be less prominent in recent publications. These areas may reflect shifts in research priorities or advances in understanding that have led to less frequent exploration.
  1. Basic Descriptive Studies of CNS Anatomy:
    There has been a noticeable decline in purely descriptive studies focusing on the anatomy of the CNS without a direct link to functional implications or clinical relevance.
  2. Non-Integrated Approaches to CNS Disorders:
    Research that does not integrate findings from multiple disciplines, such as molecular biology, clinical studies, and imaging, appears to be waning, as the journal emphasizes more holistic and interdisciplinary methods.
  3. Traditional Drug Delivery Methods:
    Interest in conventional methods of drug delivery to the CNS is decreasing, with a shift towards more innovative approaches that enhance drug efficacy and targeting.
  4. Static Models of Fluid Dynamics:
    There is a decrease in studies using static models for cerebrospinal fluid dynamics, as more researchers adopt dynamic, in vivo, or clinically relevant models.

Similar Journals

NEUROLOGICAL RESEARCH

Transforming Understanding through Cutting-Edge Research
Publisher: TAYLOR & FRANCIS LTDISSN: 0161-6412Frequency: 12 issues/year

NEUROLOGICAL RESEARCH, published by TAYLOR & FRANCIS LTD, is a distinguished journal focusing on the diverse and evolving field of neurology. Established in 1979, this journal has been a prominent platform for disseminating groundbreaking research and clinical advances up to 2024. With an ISSN of 0161-6412 and an E-ISSN of 1743-1328, it offers valuable insights for researchers, professionals, and students interested in the intricate workings of the nervous system. The journal holds a respectable Q2 ranking in the field of Medicine (miscellaneous) and Q3 in the categories of Neurology and Clinical Neurology, reflecting its commitment to high-quality research. Although NEUROLOGICAL RESEARCH does not currently offer an open access option, its contributions to the literature are vital for fostering advancements in neurological understanding and treatment. With an engaged readership and a mission to advance scientific knowledge, NEUROLOGICAL RESEARCH serves as a crucial resource for anyone dedicated to neurological health and innovation.

NEUROBIOLOGY OF DISEASE

Unlocking the Mysteries of Neurological Disorders
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCEISSN: 0969-9961Frequency: 12 issues/year

NEUROBIOLOGY OF DISEASE is a premier journal dedicated to advancing the understanding of neurological disorders and the underlying biological processes, published by Academic Press Inc, Elsevier Science. With an impressive impact factor indicative of its significance—ranked in the Q1 quartile in Neurology for 2023 and occupying the 14th rank out of 192 journals in the field of Neuroscience and Neurology—this journal serves as a critical resource for researchers, clinicians, and students alike. The journal has a rich history since its inception in 1994, continuously evolving its scope to encompass groundbreaking research and insights into neurobiological mechanisms and disease pathology. Though it currently does not provide Open Access options, NEUROBIOLOGY OF DISEASE remains a vital vessel for disseminating knowledge that significantly contributes to the field of neurology, fostering an understanding that can lead to innovative therapeutic strategies.

EXPERIMENTAL NEUROLOGY

Pioneering Discoveries in Neurology Since 1959.
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCEISSN: 0014-4886Frequency: 12 issues/year

EXPERIMENTAL NEUROLOGY is a premier academic journal published by Academic Press Inc, Elsevier Science, focusing on advancements in the fields of Developmental Neuroscience and Neurology. With an impressive Impact Factor and ranked in the Q1 quartile of both categories—positioning it among the top-tier journals—this publication has established itself as a vital resource for researchers, clinicians, and students alike. Since its inception in 1959, it has fostered the dissemination of cutting-edge research and innovative approaches to understanding neurological function and related disorders. While EXPERIMENTAL NEUROLOGY currently operates under a subscription access model, its rich archives and ongoing contributions to the field continue to inspire and inform the next generation of neurobiologists. The journal also boasts a high ranking in Scopus, placing fourth in Developmental Neuroscience and twentieth in Neurology, indicating its robust influence and scholarly significance. For those committed to advancing knowledge in these critical areas, EXPERIMENTAL NEUROLOGY is an indispensable platform for inquiry and discovery.

ACTA NEUROPATHOLOGICA

Advancing the Frontiers of Neuropathology
Publisher: SPRINGERISSN: 0001-6322Frequency: 12 issues/year

ACTA NEUROPATHOLOGICA, published by Springer, is a leading journal in the fields of cellular and molecular neuroscience, clinical neurology, and pathology, recognized for its exceptional quality and impactful research. With an impressive impact factor and currently ranked in the Q1 tier across multiple categories in 2023, this journal serves as a premier platform for the dissemination of groundbreaking findings in neuropathology. The journal's robust Scopus rankings highlight its influence, standing at #2 in Pathology and Forensic Medicine and #5 in Clinical Neurology. Since its inception in 1961, ACTA NEUROPATHOLOGICA has provided crucial insights into neurological diseases and disorders, contributing significantly to the advancement of medical science. Aimed at researchers, practitioners, and students alike, this journal fosters a deeper understanding of neurological conditions and encourages innovative approaches within the field. It is essential reading for anyone dedicated to unraveling the complexities of the nervous system.

NEUROSCIENCE

Unveiling the complexities of the nervous system.
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 0306-4522Frequency: 24 issues/year

NEUROSCIENCE, published by PERGAMON-ELSEVIER SCIENCE LTD, has established itself as a reputable journal in the field of neuroscience since its inception in 1976, continuing its contributions through 2024. With a Category Quartile ranking of Q2 in Neuroscience (miscellaneous) and a Scopus Rank of #41 out of 113, this journal represents a critical platform for the dissemination of innovative research and insights. Although it currently does not offer open access options, NEUROSCIENCE aims to advance our understanding of the nervous system by publishing high-quality original research, reviews, and methodological articles, thereby engaging a comprehensive audience of researchers, professionals, and students alike. With an impact factor that reflects its significance in the scientific community, this journal remains a go-to source for cutting-edge discoveries and scholarly discussions in the dynamic field of neuroscience.

Journal of Neuroimmune Pharmacology

Pioneering Research in Neuroimmune Pharmacology
Publisher: SPRINGERISSN: 1557-1890Frequency: 4 issues/year

The Journal of Neuroimmune Pharmacology, published by Springer, is a premier academic journal dedicated to advancing the field of pharmacology intersecting with neuroscience and immunology. With an outstanding impact factor and proudly positioned in the Q1 quartile across multiple categories, this journal showcases cutting-edge research that enhances our understanding of the neuroimmune system and its pharmacological implications. Established in 2006 and continuing through 2024, it serves as a vital resource for researchers, professionals, and students alike, offering insights into the mechanisms of drug action, disease processes, and therapeutic strategies. As a testament to its excellence, the journal ranks prominently in Scopus metrics within its discipline, making it an essential platform for disseminating high-quality research that drives innovation in immunology, allergy, neuroscience, and pharmacology.

NEUROSCIENCE RESEARCH

Exploring the Depths of Neuroscience Innovation
Publisher: ELSEVIER IRELAND LTDISSN: 0168-0102Frequency: 12 issues/year

NEUROSCIENCE RESEARCH, published by Elsevier Ireland Ltd, is a leading journal in the field of neuroscience, with a notable reputation for disseminating high-quality research that spans a variety of topics within the discipline. With an ISSN of 0168-0102 and an E-ISSN of 1872-8111, this journal serves as a vital platform for both established researchers and emerging voices in the field. Ranking in the Q2 quartile in both Medicine and Neuroscience categories, it has been recognized as a reliable source of innovative findings since its inception in 1984, with continuous publication through 2024. Although it does not currently offer Open Access options, the journal is indexed in Scopus, holding a significant position at Rank #48/113 in General Neuroscience, reflecting its contribution to advancing the understanding of neural mechanisms across various contexts. With its address anchored in Ireland, NEUROSCIENCE RESEARCH plays an essential role in bridging scientific inquiry and practical applications, making it an indispensable resource for researchers, professionals, and students dedicated to the burgeoning field of neuroscience.

Frontiers in Molecular Neuroscience

Exploring the molecular basis of the brain's mysteries.
Publisher: FRONTIERS MEDIA SAISSN: 1662-5099Frequency: 1 issue/year

Frontiers in Molecular Neuroscience, published by FRONTIERS MEDIA SA, is an esteemed open-access journal dedicated to advancing our understanding of the molecular mechanisms underlying neurological functions and disorders. Since its inception in 2008, the journal has established itself as a reputable source of cutting-edge research, earning a respectable Q2 ranking in both the fields of Cellular and Molecular Neuroscience and Molecular Biology as of 2023. With an ongoing commitment to fostering innovation, the journal presents a platform for researchers, professionals, and students to disseminate their findings and engage in scholarly discourse. The E-ISSN 1662-5099 ensures that research is readily accessible, facilitating the exchange of knowledge crucial to tackling the complexities of neurological conditions. Situated in Switzerland, the journal’s global reach is augmented by its open-access model, allowing for wide dissemination of critical research findings to a diverse audience. Join the vibrant community of scientists and practitioners who are shaping the future of molecular neuroscience through their contributions to this dynamic journal.

Acta Neuropathologica Communications

Transforming Neurological Understanding Through Research.
Publisher: BMCISSN: 2051-5960Frequency: 1 issue/year

Acta Neuropathologica Communications is a distinguished open-access journal published by BMC since 2013, focusing on the rapidly advancing fields of neurology, cellular and molecular neuroscience, and pathology. Located in the United Kingdom, this journal serves as a vital platform for researchers to disseminate significant findings that enhance our understanding of neurological disorders and their underlying mechanisms. With an impressive impact factor reflected in its Q1 ranking across multiple relevant categories, including Cellular and Molecular Neuroscience, Neurology (Clinical), and Pathology and Forensic Medicine, Acta Neuropathologica Communications stands out in the academic community for its rigorous peer-review process and commitment to high-quality research. The journal’s Scopus rankings highlight its global relevance, placing it in the top percentiles among leading research publications. Researchers, professionals, and students alike are encouraged to access and contribute to this essential resource, fostering a collaborative and informed approach to tackling the complexities of neuropathology and neuroscience.

TRENDS IN NEUROSCIENCES

Exploring the Frontiers of Brain Research
Publisher: CELL PRESSISSN: 0166-2236Frequency: 12 issues/year

TRENDS IN NEUROSCIENCES, published by CELL PRESS, is a leading journal in the field of neuroscience, offering cutting-edge insights and important developments in the rapidly evolving landscape of brain research. With an impressive Impact Factor and ranking in the top quartile (Q1) of the category for Neuroscience (miscellaneous), it is positioned as a vital resource for researchers and professionals seeking to stay abreast of the latest discoveries and trends from 1978 to the present. Specifically ranked #3 out of 113 in General Neuroscience by Scopus, this journal promotes the interdisciplinary exchange of ideas and knowledge, making it an essential platform for students and experienced scholars alike. Although it is not an Open Access journal, its value lies in its rigorous peer-review process and commitment to maintaining the highest standards of academic integrity. By continuing to explore the complexities of neural processes and behavior, TRENDS IN NEUROSCIENCES plays a crucial role in shaping the future of neuroscience research and education.